177 related articles for article (PubMed ID: 22932701)
1. A VASP-Rac-soluble guanylyl cyclase pathway controls cGMP production in adipocytes.
Jennissen K; Siegel F; Liebig-Gonglach M; Hermann MR; Kipschull S; van Dooren S; Kunz WS; Fässler R; Pfeifer A
Sci Signal; 2012 Aug; 5(239):ra62. PubMed ID: 22932701
[TBL] [Abstract][Full Text] [Related]
2. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.
Holt AW; Martin DN; Shaver PR; Adderley SP; Stone JD; Joshi CN; Francisco JT; Lust RM; Weidner DA; Shewchuk BM; Tulis DA
Cell Signal; 2016 Sep; 28(9):1364-1379. PubMed ID: 27302407
[TBL] [Abstract][Full Text] [Related]
4. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity.
Zhou Z; Sayed N; Pyriochou A; Roussos C; Fulton D; Beuve A; Papapetropoulos A
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1803-10. PubMed ID: 18635821
[TBL] [Abstract][Full Text] [Related]
6. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
Liu Y; Dillon AR; Tillson M; Makarewich C; Nguyen V; Dell'Italia L; Sabri AK; Rizzo V; Tsai EJ
J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
[TBL] [Abstract][Full Text] [Related]
7. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
Schäfer A; Flierl U; Kobsar A; Eigenthaler M; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2813-8. PubMed ID: 17023677
[TBL] [Abstract][Full Text] [Related]
8. Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.
Neo BH; Kandhi S; Wolin MS
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2295-304. PubMed ID: 21926339
[TBL] [Abstract][Full Text] [Related]
9. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
[TBL] [Abstract][Full Text] [Related]
10. The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy.
Irvine JC; Ganthavee V; Love JE; Alexander AE; Horowitz JD; Stasch JP; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(11):e44481. PubMed ID: 23144773
[TBL] [Abstract][Full Text] [Related]
11. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.
Schulz E; Tsilimingas N; Rinze R; Reiter B; Wendt M; Oelze M; Woelken-Weckmüller S; Walter U; Reichenspurner H; Meinertz T; Münzel T
Circulation; 2002 Mar; 105(10):1170-5. PubMed ID: 11889009
[TBL] [Abstract][Full Text] [Related]
12. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes.
Sporbert A; Mertsch K; Smolenski A; Haseloff RF; Schönfelder G; Paul M; Ruth P; Walter U; Blasig IE
Brain Res Mol Brain Res; 1999 Apr; 67(2):258-66. PubMed ID: 10216224
[TBL] [Abstract][Full Text] [Related]
14. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins.
Wang HG; Lu FM; Jin I; Udo H; Kandel ER; de Vente J; Walter U; Lohmann SM; Hawkins RD; Antonova I
Neuron; 2005 Feb; 45(3):389-403. PubMed ID: 15694326
[TBL] [Abstract][Full Text] [Related]
16. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
[TBL] [Abstract][Full Text] [Related]
17. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
[TBL] [Abstract][Full Text] [Related]
18. Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium.
Schlegel N; Waschke J
J Cell Physiol; 2009 Aug; 220(2):357-66. PubMed ID: 19347869
[TBL] [Abstract][Full Text] [Related]
19. The vasodilator-stimulated phosphoprotein (VASP): target of YC-1 and nitric oxide effects in human and rat platelets.
Becker EM; Schmidt P; Schramm M; Schröder H; Walter U; Hoenicka M; Gerzer R; Stasch JP
J Cardiovasc Pharmacol; 2000 Mar; 35(3):390-7. PubMed ID: 10710123
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator-Stimulated Phosphoprotein: Regulators of Adipokines Resistin and Phenotype Conversion of Epicardial Adipocytes.
Wang J; Jia Y; Wang L; Li D; Wang L; Zhu Y; Liu J; Gong J
Med Sci Monit; 2018 Aug; 24():6010-6020. PubMed ID: 30156215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
